From my Google alert this morning:

In part: "The Abbott unit had run advertising claiming that "Similac Advance
... has been clinically shown to help support the development of a baby's
immune system like breast milk ...[and results in] immune cell development,"
according to the decision.

The National Advertising Division of the Council of Better Business Bureaus,
a unit of the NARB, previously told the Abbott unit to modify that language
to avoid giving consumers any impression that Similac is "like" breast milk.


But Mead Johnson, which markets Enfamil, a competitor of Abbott's Ross unit,
appealed the decision to the NARB, hoping to restrict Ross's advertising
even further by banning them from using language suggesting that Similac
helped babies' immune systems."

Here is the link to the complete article:

http://www.brandweek.com/bw/news/pharmaceutical/article_display.jsp?vnu_cont
ent_id=1001480464


Janet Hoover, LM, IBCLC
Santa Cruz, CA 

mailto:[log in to unmask]

             ***********************************************

To temporarily stop your subscription: set lactnet nomail
To start it again: set lactnet mail (or digest)
To unsubscribe: unsubscribe lactnet
All commands go to [log in to unmask]

The LACTNET mailing list is powered by L-Soft's renowned
LISTSERV(R) list management software together with L-Soft's LSMTP(R)
mailer for lightning fast mail delivery. For more information, go to:
http://www.lsoft.com/LISTSERV-powered.html